Kanbay, M. Et Al. 2016. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.48, no.7 , 1129-1136.

Kanbay, M., Afsar, B., Siriopol, D., Unal, H. U., Karaman, M., Saglam, M., ... Eyileten, T.(2016). Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients. INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.48, no.7, 1129-1136.

Kanbay, Mehmet Et Al. "Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients," INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.48, no.7, 1129-1136, 2016

Kanbay, Mehmet Et Al. "Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.48, no.7, pp.1129-1136, 2016

Kanbay, M. Et Al. (2016) . "Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients." INTERNATIONAL UROLOGY AND NEPHROLOGY , vol.48, no.7, pp.1129-1136.

@article{article, author={Mehmet Kanbay Et Al. }, title={Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients}, journal={INTERNATIONAL UROLOGY AND NEPHROLOGY}, year=2016, pages={1129-1136} }